Municipalities as key actors of German renewable energy governance: an analysis of opportunities, obstacles, and multi-level influences

In recent years, policies to promote renewable energy have become increasingly popular among municipalities in different parts of the world. This article examines the case of Germany. It argues that municipalities, compared to other state and private actors, already have the potential to play a key role in German renewable energy governance. Although both private actors and the European Union have gained importance in the past 20 years, German municipalities still play a crucial role and can apply five distinct and important modes of governance in the field of renewable energy policy. In this regard, the notion of a general development towards a "cooperating and ensuring state", which increasingly delegates its tasks and thus becomes less important, cannot be confirmed in the field of municipal renewable energy governance in Germany.Seit einigen Jahren ist in verschiedenen Weltgegenden eine zunehmende Verbreitung kommunaler Ansätze zum Ausbau erneuerbarer Energien zu verzeichnen. Der vorliegende Artikel widmet sich deutschen Kommunen und argumentiert, dass diese im Vergleich zu anderen staatlichen Ebenen und privaten Akteuren das Potenzial haben, eine Schlüsselrolle bei der Energiewende in Deutschland zu spielen. Obwohl private Akteure ebenso wie die Europäische Union in den letzten 20 Jahren an Bedeutung gewonnen haben, spielen Kommunen hier weiterhin eine wichtige Rolle und können im Politikfeld erneuerbare Energien fünf bedeutsame und voneinander abgrenzbare Governance-Modi anwenden. Die weit verbreitete These einer stetigen Entwicklung hin zum so genannten Kooperations- und Gewährleistungsstaat, der seine Aufgaben zunehmend an Private delegiert und an Bedeutung verliert, kann im Bereich kommunaler Erneuerbare-Energien-Politik daher nicht bestätigt werden

Niemand steht über dem (Klimaschutz-)Gesetz

Weil die Regierung trotz Zielverfehlung noch immer kein Klimaschutz-Sofortprogramm verabschiedet hat, klagt der Umweltverband Bund für Umwelt und Naturschutz Deutschland e.V. (BUND) nun vor dem OVG Berlin-Brandenburg auf Beschluss eines solchen. Die Klage gibt Anlass für eine nähere Betrachtung der rechtlichen Pflichten, die das Klimaschutzgesetz (KSG) für den Fall einer Zielverfehlung auferlegt. </p

When Reporters get Hands-on with Robo-writing: Professionals Consider Automated Journalism’s Capabilities and Consequences

The availability of data feeds, the demand for news on digital devices, and advances in algorithms are helping to make automated journalism more prevalent. This article extends the literature on the subject by analysing professional journalists’ experiences with, and opinions about, the technology. Uniquely, the participants were drawn from a range of news organizations—including the BBC, CNN, and Thomson Reuters—and had first-hand experience working with robo-writing software provided by one of the leading technology suppliers. The results reveal journalists’ judgements on the limitations of automation, including the nature of its sources and the sensitivity of its “nose for news”. Nonetheless, journalists believe that automated journalism will become more common, increasing the depth, breadth, specificity, and immediacy of information available. While some news organizations and consumers may benefit, such changes raise ethical and societal issues and, counter-intuitively perhaps, may increase the need for skills—news judgement, curiosity, and scepticism—that human journalists embody

Clinical and virological characteristics of hospitalised COVID-19 patients in a German tertiary care centre during the first wave of the SARS-CoV-2 pandemic: a prospective observational study

Purpose: Adequate patient allocation is pivotal for optimal resource management in strained healthcare systems, and requires detailed knowledge of clinical and virological disease trajectories. The purpose of this work was to identify risk factors associated with need for invasive mechanical ventilation (IMV), to analyse viral kinetics in patients with and without IMV and to provide a comprehensive description of clinical course. Methods: A cohort of 168 hospitalised adult COVID-19 patients enrolled in a prospective observational study at a large European tertiary care centre was analysed. Results: Forty-four per cent (71/161) of patients required invasive mechanical ventilation (IMV). Shorter duration of symptoms before admission (aOR 1.22 per day less, 95% CI 1.10-1.37, p < 0.01) and history of hypertension (aOR 5.55, 95% CI 2.00-16.82, p < 0.01) were associated with need for IMV. Patients on IMV had higher maximal concentrations, slower decline rates, and longer shedding of SARS-CoV-2 than non-IMV patients (33 days, IQR 26-46.75, vs 18 days, IQR 16-46.75, respectively, p < 0.01). Median duration of hospitalisation was 9 days (IQR 6-15.5) for non-IMV and 49.5 days (IQR 36.8-82.5) for IMV patients. Conclusions: Our results indicate a short duration of symptoms before admission as a risk factor for severe disease that merits further investigation and different viral load kinetics in severely affected patients. Median duration of hospitalisation of IMV patients was longer than described for acute respiratory distress syndrome unrelated to COVID-19

The German National Registry of Primary Immunodeficiencies (2012-2017)

Introduction: The German PID-NET registry was founded in 2009, serving as the first national registry of patients with primary immunodeficiencies (PID) in Germany. It is part of the European Society for Immunodeficiencies (ESID) registry. The primary purpose of the registry is to gather data on the epidemiology, diagnostic delay, diagnosis, and treatment of PIDs. Methods: Clinical and laboratory data was collected from 2,453 patients from 36 German PID centres in an online registry. Data was analysed with the software Stata® and Excel. Results: The minimum prevalence of PID in Germany is 2.72 per 100,000 inhabitants. Among patients aged 1–25, there was a clear predominance of males. The median age of living patients ranged between 7 and 40 years, depending on the respective PID. Predominantly antibody disorders were the most prevalent group with 57% of all 2,453 PID patients (including 728 CVID patients). A gene defect was identified in 36% of patients. Familial cases were observed in 21% of patients. The age of onset for presenting symptoms ranged from birth to late adulthood (range 0–88 years). Presenting symptoms comprised infections (74%) and immune dysregulation (22%). Ninety-three patients were diagnosed without prior clinical symptoms. Regarding the general and clinical diagnostic delay, no PID had undergone a slight decrease within the last decade. However, both, SCID and hyper IgE- syndrome showed a substantial improvement in shortening the time between onset of symptoms and genetic diagnosis. Regarding treatment, 49% of all patients received immunoglobulin G (IgG) substitution (70%—subcutaneous; 29%—intravenous; 1%—unknown). Three-hundred patients underwent at least one hematopoietic stem cell transplantation (HSCT). Five patients had gene therapy. Conclusion: The German PID-NET registry is a precious tool for physicians, researchers, the pharmaceutical industry, politicians, and ultimately the patients, for whom the outcomes will eventually lead to a more timely diagnosis and better treatment